![Vasant Narasimhan, Global Head of Drug Development und Chief Medical Officer des Schweizer multinationalen Pharmaunternehmens Novartis, Vasant Narasimhan, Global Head of Drug Development und Chief Medical Officer des Schweizer multinationalen Pharmaunternehmens Novartis,](https://l450v.alamy.com/450vde/2dcym8f/vasant-narasimhan-global-head-of-drug-development-und-chief-medical-officer-des-schweizer-multinationalen-pharmaunternehmens-novartis-wahrend-des-choose-france-summit-am-22-januar-2018-im-chateau-de-versailles-bei-paris-prasident-emmanuel-macrons-kampagne-fur-eine-franzosische-renaissance-gerodete-am-22-januar-in-die-offensive-als-seine-regierung-140-multinationale-wirtschaftsfuhrer-vor-dem-jamboree-der-reichen-und-machtigen-in-davos-in-dieser-woche-begrusste-foto-von-christian-liewigabacapresscom-2dcym8f.jpg)
Vasant Narasimhan, Global Head of Drug Development und Chief Medical Officer des Schweizer multinationalen Pharmaunternehmens Novartis,
![Novartis al Twitter: "Shreeram Aradhye, Global Chief Medical Officer for Novartis Pharmaceuticals, joined a panel about integrated healthcare at #efpbarca to share our commitment to change the practice of medicine and improve Novartis al Twitter: "Shreeram Aradhye, Global Chief Medical Officer for Novartis Pharmaceuticals, joined a panel about integrated healthcare at #efpbarca to share our commitment to change the practice of medicine and improve](https://pbs.twimg.com/media/DYZzvtJW0AADR2m.jpg)
Novartis al Twitter: "Shreeram Aradhye, Global Chief Medical Officer for Novartis Pharmaceuticals, joined a panel about integrated healthcare at #efpbarca to share our commitment to change the practice of medicine and improve
![French President Emmanuel Macron with Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Swiss multinational pharmaceutical company Novartis during the Choose France summit, at the Chateau de Versailles, French President Emmanuel Macron with Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Swiss multinational pharmaceutical company Novartis during the Choose France summit, at the Chateau de Versailles,](https://c8.alamy.com/comp/2DCYM8E/french-president-emmanuel-macron-with-vasant-narasimhan-global-head-of-drug-development-and-chief-medical-officer-for-swiss-multinational-pharmaceutical-company-novartis-during-the-choose-france-summit-at-the-chateau-de-versailles-outside-paris-on-january-22-2018-president-emmanuel-macrons-campaign-for-a-french-renaissance-kicked-into-overdrive-on-january-22-as-his-government-welcomed-140-multinational-business-leaders-before-this-weeks-jamboree-of-the-rich-and-powerful-in-davos-photo-by-christian-liewigabacapresscom-2DCYM8E.jpg)
French President Emmanuel Macron with Vasant Narasimhan, Global Head of Drug Development and Chief Medical Officer for Swiss multinational pharmaceutical company Novartis during the Choose France summit, at the Chateau de Versailles,
![Dr. Shephard Mpofu, Chief Medical Officer, Novartis Gene Therapies, Discusses Treatment for Children with Spinal Muscular Atrophy - Docwire News Dr. Shephard Mpofu, Chief Medical Officer, Novartis Gene Therapies, Discusses Treatment for Children with Spinal Muscular Atrophy - Docwire News](https://i.ytimg.com/vi/APa_zS4qJsk/maxresdefault.jpg)